Journal of Clinical and Experimental Ophthalmology
Open Access
ISSN: 2155-9570
+44 1223 790975
ISSN: 2155-9570
+44 1223 790975
Kannan Rangaramanujam
Scientific Tracks Abstracts: J Clin Exp Ophthalmol
Yoko Miura completed her M.D. in 1997 and Ph.D. in 2002 from Osaka City University in Japan. Clinical training was completed in eye clinic of Osaka City University Hospital and since 2002 a specialist of ophthalmology. In 2005 started research work in University of Kiel in Germany and in 2009 moved to Institute of Biomedical Optics, University of Luebeck. Today engages in the research and clinical works in Institute of Biomedical Optics and Department of Ophthalmology, University of Luebeck. Leading some research projects related to retinal cell biology. Since 2010 adjunct lecturer of Osaka City University.
Kannan Rangaramanujam is a Professor of ophthalmology and the center for nanomedicine at the Wilmer Eye Institute in Johns Hopkins School of Medicine. He obtained his Ph.D. from the California Institute of Technology (1994) in Chemical Engineering, and performed post-doctoral research at the University of Minnesota. His primary research interests are in the field of dendrimer-based targeted therapeutic platforms for neuroinflammation in CNS diseases, with a focus on retinal degeneration, cerebral palsy, and traumatic brain injury. Kannan and his team have discovered ways to target neuroinflammation using dendrimers. Kannan is an author of four patents, more than 75 peer-reviewed publications. He has won several recognitions, including the NSF CAREER award, Unilever award, and is on the editorial board of Nanomedicine: nanotechnology, biology and medicine.